Skip to main content
NANOSONICS LIMITED logo

NANOSONICS LIMITED — Investor Relations & Filings

Ticker · NAN ISIN · AU000000NAN9 LEI · 549300XUBCM70BRANN81 ASX Manufacturing
Open in API
Filings indexed 1,049 across all filing types
Latest filing 2009-12-07 Capital/Financing Update
Country AU Australia
Listing ASX NAN

About NANOSONICS LIMITED

https://www.nanosonics.com.au

Nanosonics Limited is a medical technology company specializing in the development and commercialization of infection prevention solutions. The company's flagship product, the trophon system, provides automated high-level disinfection (HLD) for ultrasound probes. Utilizing a proprietary hydrogen peroxide mist technology, the trophon device ensures consistent and effective disinfection of both the probe handle and shaft, addressing the risks of cross-contamination in clinical settings. The system is designed to integrate into diagnostic workflows, offering a faster and more environmentally sustainable alternative to traditional manual chemical soaking methods. Nanosonics continues to expand its portfolio with digital traceability tools and audit-ready reporting software to enhance compliance and patient safety across global healthcare facilities.

Recent filings

Filing Released Lang Actions
A$12 Million underwritten placement completed 2 pages ?Kb
Capital/Financing Update Classification · 95% confidence The document is an announcement dated December 8, 2009, regarding the successful completion of an institutional equity placement raising A$12 million by Nanosonics Limited. It details the number of shares placed, the price per share, settlement and allotment dates, and intended use of proceeds. There is no financial statement or detailed financial report included, only a capital raising update. The document length is 3479 characters, which is relatively short and consistent with a capital/financing update announcement rather than a full financial report. Therefore, the document fits the Capital/Financing Update (CAP) category.
2009-12-07 English
Trading Halt 2 pages ?Kb
Capital/Financing Update Classification · 95% confidence The document is a market release dated 7 December 2009 from Nanosonics Limited, announcing a trading halt requested by the company pending the release of an announcement related to a possible material capital raising, including placement of shares and a share purchase plan. The text details the reasons for the trading halt, the expected timing of the announcement, and the company's contact information. There are no financial statements, detailed financial data, or full report content included. The document is short (2943 characters) and serves as an announcement about an upcoming capital raising event rather than the event details themselves. Therefore, it fits the category of a Capital/Financing Update (CAP) as it provides information about financing activities and capital structure changes.
2009-12-06 English
$12million underwritten placement plus share purchase plan 2 pages ?Kb
Capital/Financing Update Classification · 95% confidence The document is an announcement dated December 7, 2009, from Nanosonics Limited regarding an equity capital raising. It details an underwritten institutional placement of A$12 million and a non-underwritten share purchase plan (SPP) for eligible shareholders. The text focuses on the terms of the placement, pricing, purpose of the capital raise, and procedural details such as trading halt and underwriting. There are no financial statements, detailed financial analysis, or comprehensive report content. The document is relatively short (3722 characters) and serves as a formal announcement of financing activity rather than a full financial report or earnings release. Therefore, it fits the category of Capital/Financing Update (CAP).
2009-12-06 English
Investor Presentation re share placement 39 pages ?Kb
Investor Presentation Classification · 95% confidence The document is titled 'Nanosonics Limited Investor Presentation 7 December 2009' and contains detailed information about the company's products, capital raising plans, market opportunities, and financial data. It includes disclaimers typical of investor presentations and discusses forward-looking statements, risks, and investment highlights. There is no indication that this is a full financial report, audit, or regulatory filing. The content is consistent with a presentation aimed at investors to inform them about the company's strategy, financial position, and capital raising efforts. Therefore, the document fits the category of an Investor Presentation (IP). The document length (15,000 characters) and detailed content support this classification with high confidence.
2009-12-06 English
Options exercised, shares issued 8 pages ?Kb
Share Issue/Capital Change Classification · 100% confidence The document is an announcement from Nanosonics Limited regarding the issuance of new shares following the exercise of employee share options. It includes detailed information about the number of shares issued, the terms of the securities, compliance with relevant sections of the Corporations Act, and an Appendix 3B New Issue Announcement form which is a standard regulatory form used in Australia to notify the market of new securities issued. The content focuses on the issuance of shares and related regulatory disclosures rather than financial results, management changes, or other report types. The document is not a full financial report, earnings release, or management discussion, but a formal announcement of a capital change (new shares issued). Therefore, the appropriate classification is Share Issue/Capital Change (SHA). The document length and detail confirm it is not a brief notice or a report publication announcement but a substantive capital change announcement.
2009-12-02 English
Response to ASX Price Query 4 pages ?Kb
Regulatory Filings Classification · 100% confidence The document is a letter exchange between the Australian Securities Exchange (ASX) and Nanosonics Limited regarding a price query about the company's securities. The ASX is requesting information about recent price changes and whether the company is aware of any undisclosed information that could explain the trading activity. The company responds that it is not aware of any such information and confirms compliance with listing rules. The document is a regulatory communication related to compliance with continuous disclosure obligations under listing rules, specifically Listing Rule 3.1. It does not contain financial statements, earnings data, or detailed financial analysis. It is not a report, presentation, or announcement of financial results but a regulatory filing responding to a market query. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2009-11-18 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.